• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.64% Nasdaq Up1.86%

    Ceres, Inc. (CERE)

    0.39 Down 0.00(0.20%) 3:57PM EDT
    ProfileGet Profile for:
    Ceres, Inc.
    1535 Rancho Conejo Boulevard
    Thousand Oaks, CA 91320
    United States - Map
    Phone: 805-376-6500
    Website: http://www.ceres.net

    Index Membership:N/A
    Sector:Basic Materials
    Industry:Agricultural Chemicals
    Full Time Employees:44

    Business Summary 

    Ceres, Inc., an agricultural biotechnology company, develops and markets seeds and traits to produce crops for feed, forages, sugar, and other markets in North America. It uses a combination of advanced plant breeding, biotechnology, and bioinformatics to develop seed products and biotechnology traits to address various limitations and challenges facing agriculture. The company offers forage sorghum seeds used for growing feed for livestock, such as dairy and beef cattle. It also provides biotechnology traits, which enhance biomass yields; and offer yield stability and resilience to drought and other stress conditions for sugar cane and other crops. In addition, the company develops Persephone bioinformatics software that enables storage and access to large and complex datasets, as well as optimized data visualizations to view genetic data from public sources and proprietary databases. It markets its seed products under the Blade brand. Ceres, Inc. was founded in 1996 and is headquartered in Thousand Oaks, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Ceres, Inc.

    Corporate Governance 
    Ceres, Inc.’s ISS Governance QuickScore as of Jul 1, 2013 is 8. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 7; Compensation: 5.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Dr. Richard William Hamilton Ph.D., 54
    Co-Founder, Chief Exec. Officer, Pres and Director
    Mr. Paul M. Kuc , 54
    Chief Financial Officer
    Ms. Wilfriede Margareta Maria van Assche , 61
    Sr. VP, Gen. Counsel and Sec.
    Mr. Gary Koppenjan ,
    Director of Investor Relations & Communications
    Dr. Roger Ivan Pennell Ph.D., 57
    VP of Trait Devel.
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.